SNDL Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

SNDL şirketinin kazançları yıllık ortalama -5.3% oranında azalırken, Pharmaceuticals sektörünün kazançları yıllık 12.5% oranında artan oldu. Gelirler yıllık ortalama 61.4% oranında artan oldu.

Anahtar bilgiler

-5.3%

Kazanç büyüme oranı

63.7%

EPS büyüme oranı

Pharmaceuticals Sektör Büyümesi	7.3%
Gelir büyüme oranı	61.4%
Özkaynak getirisi	-9.4%
Net Marj	-12.4%
Sonraki Kazanç Güncellemesi	05 Nov 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Gelir ve Gider Dağılımı

SNDL nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

DB:VY4 Gelir, gider ve kazançlar (CAD Millions )
Tarih	Gelir	Kazançlar	G+A Giderleri	Ar-Ge Giderleri
30 Jun 24	912	-113	224	0
31 Mar 24	916	-136	228	0
31 Dec 23	909	-168	230	0
30 Sep 23	901	-211	221	1
30 Jun 23	894	-287	213	2
31 Mar 23	886	-331	196	2
31 Dec 22	712	-335	158	2
30 Sep 22	495	-266	124	3
30 Jun 22	278	-151	88	2
31 Mar 22	64	-130	60	2
31 Dec 21	56	-227	55	2
30 Sep 21	47	-228	50	2
30 Jun 21	46	-316	49	1
31 Mar 21	57	-296	45	0
31 Dec 20	61	-200	46	0
30 Sep 20	62	-170	59	1
30 Jun 20	77	-184	70	1
31 Mar 20	76	-164	80	3
31 Dec 19	64	-143	86	2
30 Sep 19	49	-156	72	2
30 Jun 19	21	-84	54	2
31 Mar 19	1	-77	37	0
31 Dec 18	0	-68	22	0
28 Feb 18	0	-13	9	0

Kaliteli Kazançlar: VY4 şu anda kârlı değil.

Büyüyen Kar Marjı: VY4 şu anda kârlı değil.

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: VY4 kârlı değildir ve zararlar son 5 yılda yılda 5.3% oranında artmıştır.

Büyüme Hızlandırma: VY4 'un son bir yıldaki kazanç büyümesinin 5 yıllık ortalamasıyla karşılaştırılması mümkün değil çünkü şu anda kârlı değil

Kazançlar vs. Sektör: VY4 kârlı olmadığından, geçmiş yıl kazanç büyümesinin Pharmaceuticals sektörüyle ( 28.7% ) karşılaştırılması zorlaşıyor.

Özkaynak Getirisi

Yüksek ROE: VY4 hissesi şu anda kârlı olmadığından negatif Özsermaye Getirisi'ne ( -9.4% ) sahiptir.

SNDL Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Anahtar bilgiler

Yakın geçmiş performans güncellemeleri

SNDL Inc. to Report Q3, 2024 Results on Nov 05, 2024

SNDL Inc. to Report Q2, 2024 Results on Aug 02, 2024

SNDL Inc. Reports Asset Impairment Charges for the First Quarter Ended March 31, 2024

First quarter 2024 earnings released: CA$0.01 loss per share (vs CA$0.13 loss in 1Q 2023)

SNDL Inc. to Report Q1, 2024 Results on May 09, 2024

Full year 2023 earnings released: CA$0.67 loss per share (vs CA$1.46 loss in FY 2022)

Recent updates

SNDL Inc. to Report Q3, 2024 Results on Nov 05, 2024

SNDL Inc. (NasdaqCM:SNDL) completed the acquisition of 34.80% stake in Nova Cannabis Inc. (TSX:NOVC).

SNDL Inc. Appoints J. Carlo to Its Board of Directors

No longer forecast to breakeven

SNDL Inc. (NasdaqCM:SNDL) agreed to acquire 34.80% stake in Nova Cannabis Inc. (TSX:NOVC) for CAD 72.39 million.

SNDL Inc. to Report Q2, 2024 Results on Aug 02, 2024

SNDL Inc., Annual General Meeting, Jul 30, 2024

New major risk - Revenue and earnings growth

SNDL Inc. Reports Asset Impairment Charges for the First Quarter Ended March 31, 2024

First quarter 2024 earnings released: CA$0.01 loss per share (vs CA$0.13 loss in 1Q 2023)

SNDL Inc. to Report Q1, 2024 Results on May 09, 2024

Full year 2023 earnings released: CA$0.67 loss per share (vs CA$1.46 loss in FY 2022)

SNDL Inc. to Report Fiscal Year 2023 Results on Mar 21, 2024

Third quarter 2023 earnings released: CA$0.08 loss per share (vs CA$0.41 loss in 3Q 2022)

SNDL Inc. (NasdaqCM:SNDL) announces an Equity Buyback for 13,100,000 shares, representing 5% for CAD 100 million.

SNDL Inc. to Report Q3, 2023 Results on Nov 13, 2023

SNDL Inc. Launches New E-Commerce Platform for its Destination Liquor Retail banner, Wine and Beyond

Second quarter 2023 earnings released: CA$0.12 loss per share (vs CA$0.31 loss in 2Q 2022)

SNDL Inc. to Report Q2, 2023 Results on Aug 14, 2023

New major risk - Share price stability

SNDL Inc. Announces Chief Financial Officer Changes

SNDL Inc., Annual General Meeting, Jul 27, 2023

SNDL Inc. to Report Q1, 2023 Results on May 15, 2023

Forecast breakeven date moved forward to 2023

Forecast breakeven date moved forward to 2023

Forecast breakeven date moved forward to 2023

SNDL Inc. Provides Earnings Guidance for the Fourth Quarter of 2022

SNDL Inc. (NasdaqCM:SNDL) completed the acquisition of Substantially all of the business and assets of Superette.

SNDL Inc. (NasdaqCM:SNDL) completed the acquisition of remaining 91.9% stake in The Valens Company Inc. (TSX:VLNS).

SNDL Inc. (NasdaqCM:SNDL) announces an Equity Buyback for 11,800,000 shares, representing 5% for CAD 100 million.

Sundial Growers Inc. (NasdaqCM:SNDL) acquired Zenabis Global Inc. from HEXO Corp. (TSX:HEXO).

SNDL Inc. to Report Q3, 2022 Results on Nov 14, 2022

SNDL Inc. (NasdaqCM:SNDL) entered into a Stalking Horse Agreement to acquire Substantially all of the business and assets of Superette.

SNDL Inc. (NasdaqCM:SNDL) entered into an arrangement agreement to acquire remaining 89.9% stake in The Valens Company Inc. (TSX:VLNS) for CAD 92.1 million.

SNDL Inc. to Report Q2, 2022 Results on Aug 12, 2022

Sundial Growers Inc. Announces Resignation of David Gordey as Chief Administrative Officer, Effective July 29, 2022

Simply Solventless Concentrates Ltd. completed the acquisition of Fully Licenced Cultivation and Processing Facility of Sundial Growers Inc.. from Sundial Growers Inc. (NasdaqCM:SNDL).

Sundial Growers Inc. (NasdaqCM:SNDL) entered into a purchase agreement to acquire Zenabis Global Inc. from HEXO Corp. (TSX:HEXO).

Sundial Growers Inc. to Report Q1, 2022 Results on May 16, 2022

Sundial Growers Inc., Annual General Meeting, Jun 27, 2022

Sundial Growers Inc. to Report Q4, 2021 Results on Apr 14, 2022

Sundial Receives 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Rule

Simply Solventless Concentrates Ltd. entered into an asset purchase agreement to acquire Fully Licenced Cultivation and Processing Facility of Sundial Growers Inc. from Sundial Growers Inc. (NasdaqCM:SNDL) for CAD 5 million.

An unknown byer acquired 25% stake in Pathway RX Inc from Sundial Growers Inc. (NasdaqCM:SNDL).

Sundial Growers Inc. (NasdaqCM:SNDL) entered into an agreement to acquire Inner Spirit Holdings Ltd. (CNSX:ISH) for approximately CAD 120 million.

Sundial and SAF Group Announce Strategic Capital Partnership

Sundial Growers Inc. to Report Q4, 2020 Results on Mar 17, 2021

Sundial Regains Compliance with Nasdaq Minimum Bid Price Rule

Sundial Growers Inc. has completed a Composite Units Offering in the amount of $100 million.

Sundial Growers Inc. Announces the Launch of Premium Concentrates Products Under Its Top Leaf Brand

Sundial Growers Inc. (NasdaqCM:SNDL) acquired Senior Secured Loans of Zenabis Investments Ltd for CAD 58.9 million.

Sundial Announces Concentrates Licence Agreement with Simply Solventless

Sundial Growers Transfers Listing to Extend Regaining Compliance Period

New 90-day high: €0.60

Revenue misses expectations

Third quarter 2020 earnings released: CA$0.53 loss per share

Sundial Growers Inc. Enters into Sales and Distribution Agreement with Choklat Inc

Sundial Growers Inc. to Report Q3, 2020 Results on Nov 11, 2020

David Ball, together with the senior management team of Bridge Farm Nurseries and Artemis Growth Partners reached an agreement to acquire Bridge Farm Nurseries Limited from Sundial Growers Inc. (NasdaqGS:SNDL) for CAD 90 million.

New 90-day low - €0.25

Sundial Growers Inc. has completed a Composite Units Offering in the amount of $20.048572 million.

Sundial Growers Inc. announced that it has received $18 million in funding

New 90-day low - €0.42

First half earnings released

Sundial Growers Inc. to Report Q2, 2020 Results on Aug 13, 2020

Gelir ve Gider Dağılımı

Kazanç ve Gelir Geçmişi

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi